Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. [electronic resource]
Producer: 20150330Description: 1369-79 p. digitalISSN:- 1554-8635
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Autophagy -- drug effects
- Dacarbazine -- adverse effects
- Dose-Response Relationship, Drug
- Female
- Humans
- Hydroxychloroquine -- adverse effects
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Staging
- Neoplasms -- drug therapy
- Temozolomide
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.